EcoDrugPlus

D(3) Dopamine Receptor-Like

Ensembl ID : ENSBSLG00000001563
Gene Symbol: LOC114853454
3 Cross references
203 Possible Orthologues:

D(4) Dopamine Receptor-Like

Ensembl ID : ENSBSLG00000026458
Gene Symbol: LOC114857032
3 Cross references
173 Possible Orthologues:

D(4) Dopamine Receptor-Like

Ensembl ID : ENSBSLG00000009796
Gene Symbol: LOC114851851
3 Cross references
175 Possible Orthologues:

Dna Methyltransferase 1

Ensembl ID : ENSBSLG00000014235
Gene Symbol: DNMT1
3 Cross references
212 Possible Orthologues:

Dna Topoisomerase 1-Like

Ensembl ID : ENSBSLG00000023553
Gene Symbol: LOC114856121
3 Cross references
208 Possible Orthologues:

Dna Topoisomerase I

Ensembl ID : ENSBSLG00000008883
Gene Symbol: TOP1
3 Cross references
201 Possible Orthologues:

Dna Topoisomerase Ii Alpha

Ensembl ID : ENSBSLG00000014346
Gene Symbol: TOP2A
3 Cross references
205 Possible Orthologues:

Dna Topoisomerase Ii Beta

Ensembl ID : ENSBSLG00000012827
Gene Symbol: TOP2B
3 Cross references
209 Possible Orthologues:

Emap Like 4

Ensembl ID : ENSBSLG00000022446
Gene Symbol: EML4
3 Cross references
205 Possible Orthologues:

Eph Receptor A3

Ensembl ID : ENSBSLG00000025578
Gene Symbol: EPHA3
3 Cross references
213 Possible Orthologues:

Fau Ubiquitin Like And Ribosomal Protein S30 Fusion

Ensembl ID : ENSBSLG00000018612
Gene Symbol: FAU
3 Cross references
299 Possible Orthologues:

Fyn Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSBSLG00000007983
Gene Symbol: FYN
3 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).